T-ANASTAFLO— 510(k) K990396
Substantially EquivalentEdwards Lifesciences Research Medical
FDA 510(k) clearance K990396 for T-ANASTAFLO, Substantially Equivalent on 1999-10-01. Applicant: Edwards Lifesciences Research Medical. Device class: 2.
Clearance details
- Applicant
- Edwards Lifesciences Research Medical
- Product code
- Code DWF
- Device class
- Class 2
- Regulation
- 21 CFR 870.4210
- Advisory panel
- Cardiovascular
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Midvale, UT, US
Recent devices under product code DWF
view allMore clearances from Edwards Lifesciences Research Medical
view all- K073559 — 18 FR. RMI ARTERIAL PERFUSION CANNULA II, 20 FR. RMI ARTERIAL PERFUSION CANNULA II
- K062429 — MODIFICATION TO EMBOL-X INTRA-AORTIC FILTER: X-SMALL, SMALL, MEDIUM, LARGE, X-LARGE WITH HEPARIN COATED MESH
- K991170 — RETROGRADE CARDIOPLEGIA CANNULA WITH DURAFLO TREATMENT, MODEL DII-RC-014
- K983791 — PERIPHERAL RETROGRADE CARDIAPLEGIA CANNULA
- K974259 — VENOUS FLEX II PERIPHERAL AND INTRA-OPERATIVE ACCESS VENOUS RETURN CANNULAE
Adverse events under product code DWF
product code DWF- Death
- 106
- Injury
- 386
- Malfunction
- 2,323
- Total
- 2,815
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Recalls naming K990396
K-number listed on FDA's recall recordMatched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K990396.
Data sourced from openFDA. This site is unofficial and independent of the FDA.